Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$11.7

Avg closing price
Price range

6 Jim Simons X.T.L. Biopharmaceuticals Trades

The first X.T.L. Biopharmaceuticals trade was made in Q4 2020. Since then Jim Simons bought shares two more times and sold shares on three occasions. The investor sold all their shares in Q1 2022 and doesn't own any shares in X.T.L. Biopharmaceuticals anymore.

Avg closing price
Price range
Sold -1.46k shares Q1 2022
Avg closing price $9.79
Price range $8.52 - $11.64
Increased shares by 4.5% (+63 shares) Q4 2021
Avg closing price $13.84
Price range $10.52 - $17.64
Sold 40.1% shares (-931 shares) Q3 2021
Avg closing price $16.11
Price range $13.72 - $20.80
Sold 4.1% shares (-100 shares) Q2 2021
Avg closing price $13.75
Price range $12.00 - $15.96
Increased shares by 98.8% (+1.21k shares) Q1 2021
Avg closing price $13.78
Price range $11.56 - $16.60
New holding (+1.22k shares) Q4 2020
Avg closing price $9.49
Price range $7.32 - $12.68

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!